296 related articles for article (PubMed ID: 21403679)
1. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.
Pezzolo A; Parodi F; Marimpietri D; Raffaghello L; Cocco C; Pistorio A; Mosconi M; Gambini C; Cilli M; Deaglio S; Malavasi F; Pistoia V
Cell Res; 2011 Oct; 21(10):1470-86. PubMed ID: 21403679
[TBL] [Abstract][Full Text] [Related]
2. Tumor origin of endothelial cells in human neuroblastoma.
Pezzolo A; Parodi F; Corrias MV; Cinti R; Gambini C; Pistoia V
J Clin Oncol; 2007 Feb; 25(4):376-83. PubMed ID: 17264333
[TBL] [Abstract][Full Text] [Related]
3. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M
Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304
[TBL] [Abstract][Full Text] [Related]
4. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.
Blanc E; Goldschneider D; Ferrandis E; Barrois M; Le Roux G; Leonce S; Douc-Rasy S; Bénard J; Raguénez G
Am J Pathol; 2003 Jul; 163(1):321-31. PubMed ID: 12819037
[TBL] [Abstract][Full Text] [Related]
5. Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.
Pezzolo A; Marimpietri D; Raffaghello L; Cocco C; Pistorio A; Gambini C; Cilli M; Horenstein A; Malavasi F; Pistoia V
Oncotarget; 2014 Nov; 5(21):10368-81. PubMed ID: 25362644
[TBL] [Abstract][Full Text] [Related]
6. The cultivation and identification of tumor stem cells from neuroblastoma derived tumor spheres.
Liu QX; Tang JY; Cai JY; Yin MZ; Li BS
Chin J Cancer; 2010 Dec; 29(12):1012-7. PubMed ID: 21114922
[TBL] [Abstract][Full Text] [Related]
7. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
8. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
[TBL] [Abstract][Full Text] [Related]
9. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
[TBL] [Abstract][Full Text] [Related]
10. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
Lovén J; Zinin N; Wahlström T; Müller I; Brodin P; Fredlund E; Ribacke U; Pivarcsi A; Påhlman S; Henriksson M
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1553-8. PubMed ID: 20080637
[TBL] [Abstract][Full Text] [Related]
11. Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
Kaneko Y; Suenaga Y; Islam SM; Matsumoto D; Nakamura Y; Ohira M; Yokoi S; Nakagawara A
Cancer Sci; 2015 Jul; 106(7):840-7. PubMed ID: 25880909
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.
Ohga N; Ishikawa S; Maishi N; Akiyama K; Hida Y; Kawamoto T; Sadamoto Y; Osawa T; Yamamoto K; Kondoh M; Ohmura H; Shinohara N; Nonomura K; Shindoh M; Hida K
Am J Pathol; 2012 Mar; 180(3):1294-1307. PubMed ID: 22245217
[TBL] [Abstract][Full Text] [Related]
13. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche.
Pietras A; Gisselsson D; Ora I; Noguera R; Beckman S; Navarro S; Påhlman S
J Pathol; 2008 Mar; 214(4):482-8. PubMed ID: 18189331
[TBL] [Abstract][Full Text] [Related]
14. WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.
Masserot C; Liu Q; Nguyen E; Gattolliat CH; Valteau-Couanet D; Bénard J; Huber C; Ségal-Bendirdjian E
Mol Oncol; 2016 Feb; 10(2):240-52. PubMed ID: 26482175
[TBL] [Abstract][Full Text] [Related]
15. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
16. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
Coulon A; Flahaut M; Mühlethaler-Mottet A; Meier R; Liberman J; Balmas-Bourloud K; Nardou K; Yan P; Tercier S; Joseph JM; Sommer L; Gross N
Neoplasia; 2011 Oct; 13(10):991-1004. PubMed ID: 22028624
[TBL] [Abstract][Full Text] [Related]
17. MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.
Wei SJ; Nguyen TH; Yang IH; Mook DG; Makena MR; Verlekar D; Hindle A; Martinez GM; Yang S; Shimada H; Reynolds CP; Kang MH
Cell Death Dis; 2020 May; 11(5):368. PubMed ID: 32409685
[TBL] [Abstract][Full Text] [Related]
18. Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
Islam SM; Suenaga Y; Takatori A; Ueda Y; Kaneko Y; Kawana H; Itami M; Ohira M; Yokoi S; Nakagawara A
Cancer Sci; 2015 Oct; 106(10):1351-61. PubMed ID: 26190440
[TBL] [Abstract][Full Text] [Related]
19. Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs.
Aravindan N; Somasundaram DB; Herman TS; Aravindan S
Cell Biol Toxicol; 2021 Jun; 37(3):461-478. PubMed ID: 32979173
[TBL] [Abstract][Full Text] [Related]
20. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
Song L; Ara T; Wu HW; Woo CW; Reynolds CP; Seeger RC; DeClerck YA; Thiele CJ; Sposto R; Metelitsa LS
J Clin Invest; 2007 Sep; 117(9):2702-12. PubMed ID: 17710228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
